Skip to main content
Premium Trial:

Request an Annual Quote

Bristol-Myers Licenses Ingenuity s Pathway Software

NEW YORK, July 26 (GenomeWeb News) - Bristol-Myers Squibb has taken a multi-year license to Ingenuity's Pathways Analysis and Pathways Knowledge Base applications, Ingenuity said today.

 

Under the agreement, Ingenuity Pathways Analysis will be available to all BMS scientists. Both Ingenuity products will be integrated with existing bioinformatics solutions at the drug company.

 

Ingenuity's Pathways Knowledge Base is a curated database of modeled relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases. The Pathways Analysis application analyzes these relationships.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.